- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Cancer Drug Shows Signs of Preventing Alzheimer's Symptoms
Science Alert reported that an FDA-approved anti-cancer drug has shown potential is slowing the first stages of Alzheimer’s disease, which has researchers looking at developing a treatment that could be taken as a preventative measure prior to the onset of symptoms.
Science Alert reported that an FDA-approved anti-cancer drug has shown potential is slowing the first stages of Alzheimer’s disease, which has researchers looking at developing a treatment that could be taken as a preventative measure prior to the onset of symptoms.
According to the article:
A team from the University of Cambridge in the UK worked with genetically modified worms that were engineered to develop Alzheimer’s disease. At various stages of the disease, the worms were given the cancer drug, bexarotene, which has seen mixed results in treating Alzheimer’s in the past.
Michele Vendruscolo, one of the team commented:
We showed that these worms that were doomed to develop Alzheimer’s disease could be rescued.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.